Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 723INDUSTRY 279NIH 84NETWORK 20OTHER_GOV 15INDIV 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 84Genitourinary 67Thoracic 30Breast 17Lymphoid 13Gynecologic 10Other hematologic neoplasm 9Tumor-Agnostic 8Dermatologic 8Head & Neck 7CNS 4Plasma cell 3Other 3Sarcoma 1Myeloid 1Classical hematology 1

Conditions

Prostatic Neoplasms 1Hereditary Sensory and Autonomic Neuropathies 1Fanconi Anemia, Complementation Group N 1Fanconi Anemia, Complementation Group D1 1

Interventions

olaparib 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × Classical hematology × Clear all
NCT04038502 2025-08-20

COBRA

VA Office of Research and Development

Phase 2 Recruiting
100 enrolled
Classical hematologyGenitourinary

Fanconi Anemia, Complementation Group N, Fanconi Anemia, Complementation Group D1, Hereditary Sensory and Autonomic Neuropathies, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡